Sleep and Cardiometabolic Disease: A Wearable-Electronic Health Record Study in the US All of Us Research Program
Circulation: Population Health and Outcomes · 02.11.2026
DOI: 10.1161/circoutcomes.126.014445 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation: Population Health and Outcomes, online erschienen am 02.11.2026. Verfasst von Anh Khoa Tran und 1 weiteren Autor:innen. Beteiligte Einrichtung: University of Maryland Medical System, Baltimore, MD.
Abstract (Originalsprache)
Background
Sleep health spans duration, quality, regularity, and timing, yet Life's Essential 8 scores sleep by duration alone, and regularity studies used about 1 week of data. How these dimensions, measured over months, relate to incident cardiometabolic disease is unknown, as is whether nightly sleep-cycle structure adds information.
Methods
This cohort study included US adults in the All of Us Research Program with linked Fitbit and electronic health records (2009–2023). We derived 11 sleep metrics over a 180-day baseline (≥90 valid nights). Incident diagnoses, grouped into phecodes, were counted after a 180-day washout to limit reverse causation. Primary analyses related these metrics to prespecified endpoints, including a CVD composite (myocardial infarction, heart failure, cardiomyopathy, or ischemic stroke), heart failure, hypertension, and type 2 diabetes. Cox models adjusted for demographic, socioeconomic, lifestyle, and comorbidity factors. Exploratory analyses examined wearable-estimated sleep cycles (7,199 participants; 1,017,812 sleep-stage nights).
Results
Among 10,362 participants (median age, 53 years; 70% female), 230 developed the CVD composite (median follow-up, 3.7 years). Each 1-SD (29-minute) higher night-to-night variability in sleep duration was associated with higher CVD composite risk (hazard ratio, 1.24 [95% CI, 1.09–1.41]), as was higher variability in bedtime (1.23 [1.10–1.37]), waketime (1.20 [1.09–1.32]), and midpoint (1.21 [1.09–1.35]); mean sleep duration was not (0.96 [0.85–1.08]). Variability in sleep duration was also associated with heart failure (1.32 [1.13–1.55]), hypertension (1.16 [1.08–1.25]), and type 2 diabetes (1.20 [1.07–1.35]). More sleep cycles were associated with lower atrial arrhythmia risk (0.72 [0.58–0.89]), independent of sleep duration, regularity, and timing (0.58 [0.44–0.77]).
Conclusions
Night-to-night irregularity in sleep duration and timing was associated with the CVD composite, heart failure, hypertension, and type 2 diabetes; mean duration was not associated with the CVD composite. More wearable-estimated sleep cycles were associated with lower atrial arrhythmia risk beyond conventional sleep metrics, a novel finding requiring confirmation.
Autor:innen und Institutionen
- University of Maryland Medical System, Baltimore, MD.
- Kirby Neurobiology Center, Boston Children's Hospital and Harvard Medical School, Boston, MA.
ORCID-Profile: Anh Khoa Tran
Zitieren
APA
Tran, A. K., & Nguyen, M. T. V. (2026). Sleep and Cardiometabolic Disease: A Wearable-Electronic Health Record Study in the US All of Us Research Program. Circulation: Population Health and Outcomes. https://doi.org/10.1161/circoutcomes.126.014445
Vancouver
Tran AK, Nguyen MTV. Sleep and Cardiometabolic Disease: A Wearable-Electronic Health Record Study in the US All of Us Research Program. Circulation: Population Health and Outcomes. 2026. doi:10.1161/circoutcomes.126.014445
BibTeX
@article{Tran2026,
author = {Tran, Anh Khoa and Nguyen, Minh Tuan Viet},
title = {Sleep and Cardiometabolic Disease: A Wearable-Electronic Health Record Study in the US All of Us Research Program},
journal = {Circulation: Population Health and Outcomes},
year = {2026},
doi = {10.1161/circoutcomes.126.014445}
}
EUVIMED